title: Cholinergic afferents to the locus coeruleus and noradrenergic afferents to the medial septum mediate LTP-reinforcement in the dentate gyrus by stimulation of the amygdala.
abstract: Transient long-term potentiation (E-LTP) can be transformed into a long-lasting LTP (L-LTP) in the dentate gyrus (DG) by behavioral stimuli with high motivational content. Previous research from our group has identified several brain structures, such as the basolateral amygdala (BLA), the locus coeruleus (LC), the medial septum (MS) and transmitters as noradrenaline (NA) and acetylcholine (ACh) that are involved in these processes. Here we have investigated the functional interplay among brain structures and systems which result in the conversion of a E-LTP into a L-LTP (reinforcement) by stimulation of the BLA (BLA-R). We used topical application of specific drugs into DG, and other targets, while following the time course of LTP induced by stimulation of the perforant pathway (PP) to study their specific contribution to BLA-R. One injection cannula, a recording electrode in the DG and stimulating electrodes in the PP and the BLA were stereotactically implanted one week before electrophysiological experiments. Topical application of atropine or propranolol into the DG blocked BLA-R in both cases, but the effect of propranolol occurred earlier, suggesting a role of NA within the DG during an intermediate stage of LTP maintenance. The injection of lidocaine into the LC abolished BLA-R indicating that the LC is part of the functional neural reinforcing system. The effect on the LC is mediated by cholinergic afferents because application of atropine into the LC produced the same effect. Injection of lidocaine inactivating the MS also abolished BLA-R. This effect was mediated by noradrenergic afferents (probably from the LC) because the application of propranolol into the MS prevented BLA-R. These findings suggest a functional loop for BLA-R involving cholinergic afferents to the LC, a noradrenergic projection from the LC to the DG and the MS, and finally, the cholinergic projection from the MS to the DG.
authors.affiliation: International Center for Neurological Restoration, Havana, Cuba.
authors.forename: Jorge A
authors.initials: JA
authors.lastname: Bergado
authors.forename: Sabine
authors.initials: S
authors.lastname: Frey
authors.forename: Jeffrey
authors.initials: J
authors.lastname: López
authors.forename: William
authors.initials: W
authors.lastname: Almaguer-Melian
authors.forename: Julietta U
authors.initials: JU
authors.lastname: Frey
mesh_terms: D000109:Acetylcholine / Q000378:metabolism*; D000679:Amygdala / Q000502:physiology*; D000704:Analysis of Variance; D000818:Animals; D002799:Cholinergic Fibers / Q000378:metabolism; D018891:Dentate Gyrus / Q000502:physiology; D008125:Locus Coeruleus / Q000502:physiology; D017774:Long-Term Potentiation / Q000502:physiology*; D008297:Male; D008568:Memory / Q000502:physiology; D009434:Neural Pathways / Q000502:physiology*; D009473:Neuronal Plasticity / Q000502:physiology; D009475:Neurons, Afferent / Q000378:metabolism*; D009638:Norepinephrine / Q000378:metabolism*; D051381:Rats; D017208:Rats, Wistar; D012054:Reinforcement, Psychology; D020665:Septum of Brain / Q000502:physiology; D013997:Time Factors
chemical_list: D000109:Acetylcholine; D009638:Norepinephrine